Virtu Financial’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-122,696
| Closed | -$66K | – | 1288 |
|
|
2024
Q4 | $66K | Buy |
122,696
+21,688
| +21% | +$11.7K | ﹤0.01% | 1108 |
|
|
2024
Q3 | $96K | Buy |
101,008
+21,769
| +27% | +$20.7K | 0.01% | 920 |
|
|
2024
Q2 | $77K | Buy |
+79,239
| New | +$77K | 0.01% | 853 |
|
|
2024
Q1 | – | Sell |
-28,406
| Closed | -$23K | – | 1354 |
|
|
2023
Q4 | $23K | Buy |
+28,406
| New | +$23K | ﹤0.01% | 1301 |
|
|
2023
Q2 | – | Sell |
-88,234
| Closed | -$96K | – | 1461 |
|
|
2023
Q1 | $96K | Buy |
88,234
+58,131
| +193% | +$63.2K | 0.01% | 993 |
|
|
2022
Q4 | $44K | Sell |
30,103
-10,400
| -26% | -$15.2K | 0.01% | 1105 |
|
|
2022
Q3 | $44K | Buy |
40,503
+23,175
| +134% | +$25.2K | ﹤0.01% | 1229 |
|
|
2022
Q2 | $29K | Sell |
17,328
-7,142
| -29% | -$12K | ﹤0.01% | 1253 |
|
|
2022
Q1 | $50K | Buy |
+24,470
| New | +$50K | ﹤0.01% | 1132 |
|
|
2021
Q4 | – | Sell |
-47,542
| Closed | -$246K | – | 1646 |
|
|
2021
Q3 | $246K | Buy |
+47,542
| New | +$246K | 0.02% | 811 |
|
|
2020
Q3 | – | Sell |
-19,845
| Closed | -$199K | – | 994 |
|
|
2020
Q2 | $199K | Buy |
+19,845
| New | +$199K | 0.02% | 733 |
|
|
2018
Q1 | – | Sell |
-60,473
| Closed | -$404K | – | 1888 |
|
|
2017
Q4 | $404K | Buy |
60,473
+32,422
| +116% | +$217K | 0.02% | 1008 |
|
|
2017
Q3 | $230K | Buy |
+28,051
| New | +$230K | 0.01% | 1679 |
|